Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(1170)
Christopher P. Cannon
184
Sabina A. Murphy
176
Elliott M. Antman
164
Carolyn H. McCabe
156
David A. Morrow
141
Journals
(46)
J AMER COLL CARDIOL
123
AMER HEART J
52
AMER J CARDIOL
51
Circulation
17
EUR HEART J
17
Keywords
(418)
Embed
Subscribe
Academic
Authors
Eugene Braunwald
Eugene Braunwald,Harvard University,Cardiology,Neuroscience,Oncology
Edit
Eugene Braunwald
Harvard University
Publications:
503
|
Citations:
20881
Fields:
Cardiology
,
Neuroscience
,
Oncology
View FAQ about top research areas and Fields of study
Collaborated with
1170 co-authors
from 1991 to 2011
|
Cited by
38462 authors
Cumulative
Annual
Sort by:
Publications
(503)
BibTeX
|
RIS
|
RefWorks
Download
Safety and Tolerability of Pravastatin in Long-Term Clinical Trials Prospective Pravastatin Pooling (PPP) Project
(
Citations: 33
)
Marc A. Pfeffer
,
Anthony Keech
,
Frank M. Sacks
,
Stuart M. Cobbe
,
Andrew Tonkin
,
Robert P. Byington
,
Barry R. Davis
,
Carola P. Friedman
,
Eugene Braunwald
Published in 2011.
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes
(
Citations: 34
)
Jessica L. Mega
,
Sandra L. Close
,
Stephen D. Wiviott
,
Lei Shen
,
Richard D. Hockett
,
John T. Brandt
,
Joseph R. Walker
,
Elliott M. Antman
,
William L. Macias
,
Eugene Braunwald
,
Marc S. Sabatine
Published in 2011.
Effect of Ranolazine, an Antianginal Agent With Novel Electrophysiological Properties, on the Incidence of Arrhythmias in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Results From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) Randomized Controlled Trial
(
Citations: 27
)
Benjamin M. Scirica
,
David A. Morrow
,
Hanoch Hod
,
Sabina A. Murphy
,
Luiz Belardinelli
,
Chester M. Hedgepeth
,
Peter Molhoek
,
Freek W. A. Verheugt
,
Bernard J. Gersh
,
Carolyn H. McCabe
,
Eugene Braunwald
Published in 2011.
Implications of Upstream Glycoprotein IIb/IIIa Inhibition and Coronary Artery Stenting in the Invasive Management of Unstable Angina/Non-ST-Elevation Myocardial Infarction A Comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB Trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 Trial
(
Citations: 13
)
Marc S. Sabatine
,
David A. Morrow
,
Robert P. Giugliano
,
Sabina A. Murphy
,
Laura A. Demopoulos
,
Peter M. DiBattiste
,
William S. Weintraub
,
Carolyn H. McCabe
,
Elliott M. Antman
,
Christopher P. Cannon
,
Eugene Braunwald
Published in 2011.
Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome
(
Citations: 4
)
C. Michael Gibson
,
Jessica L. Mega
,
Paul Burton
,
Shinya Goto
,
Freek Verheugt
,
Christoph Bode
,
Alexei Plotnikov
,
Xiang Sun
,
Nancy Cook-Bruns
,
Eugene Braunwald
Journal:
American Heart Journal - AMER HEART J
, vol. 161, no. 5, pp. 815-821.e6, 2011
Sort by:
Citations
(20881 times by 14241 publications)
Panel discussion 2
Susan Ellenberg
,
Bryan Luce
,
Tom Fleming
,
Jay Siegel
,
Brian Strom
,
Miguel Hernán
,
Robert Temple
,
Dave Sackett
,
Cheryl Bourguignon
,
Justin Bekelman
,
Don Berry
,
Matthew Rotelli
http://academic.research.microsoft.com/io.ashx?type=5&id=57145716&selfId1=716251&selfId2=0&maxNumber=12&query=
Journal:
Clinical Trials - CLIN TRIALS
, vol. 9, no. 1, pp. 66-79, 2012
Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record
J T Delaney
,
A H Ramirez
,
E Bowton
,
J M Pulley
,
M A Basford
,
J S Schildcrout
,
Y Shi
,
R Zink
,
M Oetjens
,
H Xu
,
J H Cleator
,
E Jahangir
http://academic.research.microsoft.com/io.ashx?type=5&id=56546969&selfId1=716251&selfId2=0&maxNumber=12&query=
Journal:
Clinical Pharmacology & Therapeutics - CLIN PHARMACOL THER
, vol. 91, no. 2, pp. 257-263, 2012
Clinical Trial Educator program – a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial
Brigitte Kendall
,
Reto Städeli
,
Belinda Schegg
,
Martin Olbrich
,
Edmond Chen
,
Rona Harmelin-Kadouri
,
Peter Aurup
,
Tilmann Schwab
,
Steven K Hildemann
Journal:
Clinical Trials - CLIN TRIALS
, vol. 9, no. 3, pp. 358-366, 2012
Description of Response to Aspirin and Clopidogrel in Outpatients With Coronary Artery Disease Using Multiple Electrode Impedance Aggregometry
Grigoris T. Gerotziafas
,
John Zarifis
,
Anastasia Bandi
,
Lambros Mossialos
,
Vasso Galea
,
George Tsinopoulos
,
Mourad Chaari
,
Hela Baccouche
,
Mouna Sassi
,
Ismail Elalamy
Journal:
Clinical and Applied Thrombosis-hemostasis - CLIN APPL THROMB-HEMOST
, vol. 18, no. 4, pp. 356-363, 2012
Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration (ACTFAST) Study
Milan Gupta
,
Pierre Martineau
,
Thang Tran
,
Jean-Pierre Després
,
Allan Gaw
,
Eduardo de Teresa
,
Csaba Farsang
,
Gian Franco Gensini
,
Lawrence A. Leiter
,
Luis Miguel Blanco-Colio
,
Jesús Egido
,
Anatoly Langer
Journal:
Journal of Clinical Pharmacology - J CLIN PHARMACOL
, vol. 52, no. 6, pp. 850-858, 2012
Comments